{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:29:06Z","timestamp":1793834946137,"version":"4.6.1"},"reference-count":280,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ibneur.2022.09.007","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:13:36Z","timestamp":1664201616000},"page":"330-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Daniele","family":"Caligiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Giocondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Silvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2022.09.007_bib1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest Study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The vulnerable ventral tegmental area in Parkinson\u2019s disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.ibneur.2022.09.007_bib4","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.82808","article-title":"The relationship between alpha-synuclein (SNCA) gene polymorphisms and development risk of Parkinson\u2019s disease","author":"Alkanli","year":"2020","journal-title":"Synucleins\u00a0Biochem. Role Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnagi.2019.00130","article-title":"The gut-brain axis in neurodegenerative diseases and relevance of the Canine Model: a review","volume":"11","author":"Ambrosini","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archneur.61.8.1249","article-title":"Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease","volume":"61","author":"Assal","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib8","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ibneur.2022.09.007_bib9","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/brain\/awx137","article-title":"Cerebral quantitative susceptibility mapping predicts amyloid-\u03b2-related cognitive decline","volume":"140","author":"Ayton","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2022.09.007_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/bs.pbr.2020.07.016","article-title":"Alterations and interactions of subcortical modulatory systems in Alzheimer's disease","volume":"261","author":"Babi\u0107 Leko","year":"2021","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.20370","article-title":"Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease","volume":"20","author":"Bara-Jimenez","year":"2005","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.ibneur.2022.09.007_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4103\/1673-5374.270297","article-title":"Locus coeruleus-norepinephrine: basic functions and insights into Parkinson's disease","volume":"15","author":"Bari","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib13","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1523\/JNEUROSCI.1402-13.2013","article-title":"Changes in brain function occur years before the onset of cognitive impairment","volume":"33","author":"Beason-Held","year":"2013","journal-title":"J. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.ibneur.2022.09.007_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.13425","article-title":"Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics","volume":"139","author":"Belaidi","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.mp.4000949","article-title":"Early experience and serotonin transporter gene variation interact to influence primate CNS function","volume":"7","author":"Bennett","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes \u2014 key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib17","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/brain\/awz193","article-title":"Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases","volume":"142","author":"Betts","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2022.09.007_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-2236(03)00038-9","article-title":"Presymptomatic compensation in Parkinson's disease is not dopamine-mediated","volume":"26","author":"Bezard","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/1549168041553071","article-title":"Catecholamines and protein deposition in parkinson\u2019s and Alzheimer's disease: old medicine, new targets","volume":"7","author":"Bharath","year":"2004","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib20","doi-asserted-by":"crossref","first-page":"G529","DOI":"10.1152\/ajpgi.00058.2020","article-title":"Parkinson\u2019s disease: Are gut microbes involved?","volume":"319","author":"Bhattarai","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbadis.2004.08.014","article-title":"Tau, tangles, and Alzheimer\u2019s disease","volume":"1739","author":"Binder","year":"2005","journal-title":"Biochim. Et. Biophys. Acta BBA Mol. Basis Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","article-title":"Compensatory mechanisms in Parkinson's disease: circuits adaptations and role in disease modification","volume":"298","author":"Blesa","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/mp.2012.35","article-title":"A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology","volume":"18","author":"Bogdan","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","article-title":"Neuronal degeneration in locus ceruleus and cortical correlates of alzheimer disease","volume":"1","author":"Bondareff","year":"1987","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1002-1050","article-title":"Pesticide-Parkinson link explored","volume":"8","author":"Bonetta","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ibneur.2022.09.007_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2019.04.017","article-title":"Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer","volume":"129","author":"Bono","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib27","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1523\/JNEUROSCI.3465-08.2008","article-title":"Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis","volume":"28","author":"Boulet","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib28","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.3233\/JPD-179001","article-title":"Neuropathological staging of brain pathology in sporadic Parkinson\u2019s disease: separating the wheat from the chaff","volume":"7","author":"Braak","year":"2017","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2022.09.007_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib31","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0166-2236(94)90013-2","article-title":"Synuclein proteins and Alzheimer\u2019s disease","volume":"17","author":"Brookes","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/NPP30104","article-title":"Differential degeneration of the locus coeruleus in dementia subtypes","volume":"30","author":"Brunnstr\u00f6m","year":"2011","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib35","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.WNL.0000158423.05224.7F","article-title":"The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs","volume":"64","author":"Burns","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fnins.2018.00626","article-title":"\u03b1-synuclein and noradrenergic modulation of immune cells in Parkinson\u2019s disease pathogenesis","volume":"12","author":"Butkovich","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib37","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1523\/JNEUROSCI.1468-19.2020","article-title":"Transgenic mice expressing human \u03b1-synuclein in noradrenergic neurons develop locus coeruleus pathology and nonmotor features of Parkinson's disease","volume":"40","author":"Butkovich","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ddr.21784","article-title":"Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson\u2019s disease","volume":"82","author":"Cacabelos","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib39","first-page":"1","article-title":"Parkinson\u2019s disease as a system-level disorder","volume":"2","author":"Caligiore","year":"2016","journal-title":"npj Parkinson\u2019s"},{"key":"10.1016\/j.ibneur.2022.09.007_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12311-016-0763-3","article-title":"Consensus paper: towards a systems-level view of cerebellar function: the interplay between cerebellum, basal ganglia, and cortex","volume":"16","author":"Caligiore","year":"2017","journal-title":"Cerebellum"},{"key":"10.1016\/j.ibneur.2022.09.007_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fnins.2019.00550","article-title":"Different dopaminergic dysfunctions underlying parkinsonian akinesia and tremor","volume":"13","author":"Caligiore","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-200276","article-title":"Computational modeling of catecholamines dysfunction in Alzheimer\u2019s disease at pre-plaque stage","volume":"77","author":"Caligiore","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib43","article-title":"Increasing serotonin to reduce Parkinsonian tremor","volume":"66","author":"Caligiore","year":"2021","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib44","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11064-018-2492-0","article-title":"Impact of coffee and cacao purine metabolites on neuroplasticity and neurodegenerative disease","volume":"44","author":"Camandola","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1471-4159.2005.03556.x","article-title":"Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex","volume":"96","author":"Carboni","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/0735-7044.116.4.553","article-title":"Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in rats","volume":"116","author":"Cardinal","year":"2002","journal-title":"Behav. Neurosci."},{"issue":"19","key":"10.1016\/j.ibneur.2022.09.007_bib47","article-title":"Role of the gut microbiota in the development of various neurological diseases. Papel de la microbiota intestinal en el desarrollo de diferentes enfermedades neurol\u00f3gicas","volume":"S0213\u20134853","author":"Castillo-\u00c1lvarez","year":"2021","journal-title":"Neurologia"},{"key":"10.1016\/j.ibneur.2022.09.007_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.biopsych.2017.12.018","article-title":"\u03b1-synuclein oligomers induce a unique toxic tau strain","volume":"84","author":"Castillo-Carranza","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-2627-5_1","article-title":"Alzheimer\u2019s as a systems-level disease involving the interplay of multiple cellular networks","volume":"1303","author":"Castrillo","year":"2016","journal-title":"Methods Mol. Biol. (Clifton, N. J. )"},{"key":"10.1016\/j.ibneur.2022.09.007_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnint.2013.00025","article-title":"Serotonin modulation of cortical neurons and networks","volume":"7","author":"Celada","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/476041","article-title":"Gastrointestinal biopsies for the diagnosis of alpha-synuclein pathology in Parkinson's disease","volume":"2015","author":"Cersosimo","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.ibneur.2022.09.007_bib52","doi-asserted-by":"crossref","first-page":"fcab029","DOI":"10.1093\/braincomms\/fcab029","article-title":"Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer\u2019s disease","volume":"3","author":"Ceyz\u00e9riat","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.ibneur.2022.09.007_bib53","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00702-020-02180-4","article-title":"Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements","volume":"127","author":"Chen","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ibneur.2022.09.007_bib54","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-\u03b2 levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2022.09.007_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/acschemneuro.5b00135","article-title":"Serotonin: a new hope in Alzheimer\u2019s disease?","volume":"6","author":"Claeysen","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib56","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12640-009-9073-6","article-title":"Role of synucleins in Alzheimer\u2019s disease","volume":"16","author":"Crews","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib57","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejim.2015.08.012","article-title":"Do statins prevent Alzheimer\u2019s disease? A narrative review","volume":"26","author":"Daneschvar","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ibneur.2022.09.007_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-171018","article-title":"Volume and connectivity of the ventral tegmental area are linked to neurocognitive signatures of Alzheimer\u2019s disease in humans","volume":"63","author":"De Marco","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. JAD"},{"key":"10.1016\/j.ibneur.2022.09.007_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnsys.2011.00031","article-title":"Noradrenaline and Parkinson\u2019s disease","volume":"5","author":"Delaville","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2011.11.024","article-title":"Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism","volume":"202","author":"Delaville","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2022.09.007_bib62","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/mds.25882","article-title":"Gut feelings about smoking and coffee in Parkinson\u2019s disease","volume":"29","author":"Derkinderen","year":"2014","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.ibneur.2022.09.007_bib63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson\u2019s disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/157015906776359559","article-title":"On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?","volume":"4","author":"Devoto","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0306-4522(00)00561-3","article-title":"m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors","volume":"103","author":"Di Giovanni","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2022.09.007_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-6147(00)01688-6","article-title":"Role of 5-HT(2C) receptors in the control of central dopamine function","volume":"22","author":"Di Matteo","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0079-6123(08)00902-3","article-title":"Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies","volume":"172","author":"Di Matteo","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"s1","key":"10.1016\/j.ibneur.2022.09.007_bib68","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib69","first-page":"149","article-title":"Nouvelles tendances \u00e9pid\u00e9miologiques de la maladie d\u2019Alzheimer [Epidemiology of Alzheimer's disease: latest trends]","volume":"70","author":"Dumurgier","year":"2020","journal-title":"La Rev. du Prat."},{"key":"10.1016\/j.ibneur.2022.09.007_bib70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2377-13-190","article-title":"Alcohol use disorders and risk of Parkinson\u2019s disease: findings from a Swedish national cohort study 1972-2008","volume":"13","author":"Eriksson","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib71","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.26048","article-title":"Norepinephrine deficiency in Parkinson\u2019s disease: the case for noradrenergic enhancement","volume":"29","author":"Espay","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neubiorev.2018.10.004","article-title":"The hidden side of Parkinson\u2019s disease: studying pain, anxiety and depression in animal models","volume":"96","author":"Faivre","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.bbapap.2011.02.008","article-title":"The neurotransmitter serotonin interrupts \u03b1-synuclein amyloid maturation","volume":"1814","author":"Falsone","year":"2011","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.ibneur.2022.09.007_bib74","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00259-020-04683-4","article-title":"High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson\u2019s disease cohort","volume":"47","author":"Fazio","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ibneur.2022.09.007_bib75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-3565(24)37011-9","article-title":"Effects of noradrenergic lesions on MPTP\/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions","volume":"283","author":"Fornai","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ibneur.2022.09.007_bib76","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","article-title":"Pesticide exposure and Parkinson's disease: epidemiological evidence of association","volume":"33","author":"Freire","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib77","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.3390\/ijms21228666","article-title":"Alpha-synuclein in the gastrointestinal tract as a potential biomarker for early detection of Parkinson\u2019s disease","volume":"21","author":"Fricova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib78","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0306-4522(00)00092-0","article-title":"The central nucleus of the amygdala projection to dopamine subpopulations in primates","volume":"97","author":"Fudge","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2022.09.007_bib79","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/jmf.2014.7000","article-title":"The gut microbiome and the brain","volume":"17","author":"Galland","year":"2014","journal-title":"J. Med. Food"},{"key":"10.1016\/j.ibneur.2022.09.007_bib80","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1007\/s11033-014-3484-z","article-title":"Association between 5-HTTLPR polymorphism and Parkinson's disease: a meta analysis","volume":"41","author":"Gao","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ibneur.2022.09.007_bib81","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1096-9861(19961028)374:4<555::AID-CNE6>3.0.CO;2-0","article-title":"Direct catecholaminergic-cholinergic interactions in the basal forebrain. II. Substantia nigra-ventral tegmental area projections to cholinergic neurons","volume":"374","author":"Gaykema","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fncel.2021.626128","article-title":"Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease","volume":"15","author":"Gcwensa","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib83","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/nu10060708","article-title":"Changes of colonic bacterial composition in parkinson\u2019s disease and other neurodegenerative diseases","volume":"10","author":"Gerhardt","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ibneur.2022.09.007_bib84","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib85","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1017\/S0033291714002293","article-title":"The influence of negative life events on hippocampal and amygdala volumes in old age: a life-course perspective","volume":"45","author":"Gerritsen","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ibneur.2022.09.007_bib86","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A","article-title":"Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra","volume":"35","author":"Gervais","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.ibneur.2022.09.007_bib87","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fneur.2018.00295","article-title":"Alpha-synuclein: from early synaptic dysfunction to neurodegeneration","volume":"9","author":"Ghiglieri","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib88","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.52.2.193","article-title":"The substantia nigra and ventral tegmental area in Alzheimer\u2019s disease and Down's syndrome","volume":"52","author":"Gibb","year":"1989","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.25298","article-title":"Enteric alpha-synuclein expression is increased in Parkinson\u2019s disease but not Alzheimer's disease","volume":"28","author":"Gold","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib90","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/mds.870120607","article-title":"Symptoms and duration of the prodromal phase in Parkinson\u2019s disease","volume":"12","author":"Gonera","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib91","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00213-019-05265-5","article-title":"Do your gut microbes affect your brain dopamine?","volume":"236","author":"Gonz\u00e1lez-Arancibia","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib92","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3233\/JAD-161078","article-title":"Pupillary responses as a biomarker of early risk for Alzheimer\u2019s disease","volume":"56","author":"Granholm","year":"2017","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"key":"10.1016\/j.ibneur.2022.09.007_bib93","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fneur.2019.00756","article-title":"A novel ensemble-based machine learning algorithm to predict the conversion from mild cognitive impairment to Alzheimer\u2019s disease using socio-demographic characteristics, clinical information, and neuropsychological measures","volume":"10","author":"Grassi","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fncel.2016.00293","article-title":"Early degeneration of both dopaminergic and serotonergic axons \u2013 a common mechanism in parkinson\u2019s disease","volume":"10","author":"Grosch","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18097\/PBMC20196501021","volume":"65","author":"Gushcha","year":"2019","journal-title":"Biomeditsinskaia Khimiia"},{"key":"10.1016\/j.ibneur.2022.09.007_bib96","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson\u2019s disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib97","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib98","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2021.641101","article-title":"Locus coeruleus malfunction is linked to psychopathology in prodromal dementia with lewy bodies","volume":"13","author":"Hansen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib99","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2022.09.007_bib100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","article-title":"The role of acetylcholine in learning and memory","volume":"16","author":"Hasselmo","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib101","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.0b013e3181dd4423","article-title":"Occupational exposure to pesticides increases the risk of incident AD: the Cache County study","volume":"74","author":"Hayden","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib102","doi-asserted-by":"crossref","first-page":"0","DOI":"10.4103\/1673-5374.145380","article-title":"Age-dependent loss of cholinergic neurons in learning and memory-related brain regions and impaired learning in SAMP8 mice with trigeminal nerve damage","volume":"9","author":"He","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib103","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0278-5846(92)90106-O","article-title":"Neurotransmitter changes in early- and late-onset alzheimer-type dementia","volume":"16","author":"Heii","year":"1992","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib104","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.27224","article-title":"The cerebral basis of Parkinsonian tremor: a network perspective","volume":"33","author":"Helmich","year":"2018","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.ibneur.2022.09.007_bib105","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","article-title":"Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis","volume":"22","author":"Henderson","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib106","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib107","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","article-title":"Beyond the neuron\u2013cellular interactions early in Alzheimer disease pathogenesis","volume":"20","author":"Henstridge","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of \u03b1-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ibneur.2022.09.007_bib109","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pnpbp.2018.04.015","article-title":"Alcohol, microbiome, and their effect on psychiatric disorders","volume":"85","author":"Hillemacher","year":"2018","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/1531-8249(199901)45:1<82::AID-ART14>3.0.CO;2-T","article-title":"Increased activity of surviving locus ceruleus neurons in Alzheimer\u2019s disease","volume":"45","author":"Hoogendijk","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib111","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.euroneuro.2020.12.013","article-title":"A case-control study of the locus coeruleus degeneration in Alzheimer's disease","volume":"43","author":"Hou","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib112","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib113","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1007\/s12035-017-0703-3","article-title":"Ethanol alters APP processing and aggravates alzheimer-associated phenotypes","volume":"55","author":"Huang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib114","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/mds.22013","article-title":"Low LDL cholesterol and increased risk of Parkinson\u2019s disease: prospective results from Honolulu-Asia Aging Study","volume":"23","author":"Huang","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00221-013-3621-2","article-title":"The serotonergic system in motor and non-motor manifestations of Parkinson\u2019s disease","volume":"230","author":"Huot","year":"2013","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib116","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pneurobio.2011.08.004","article-title":"The serotonergic system in Parkinson's disease","volume":"95","author":"Huot","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib117","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-190954","article-title":"In vivo MRI structural and PET metabolic connectivity study of dopamine pathways in Alzheimer\u2019s disease","volume":"75","author":"Iaccarino","year":"2020","journal-title":"J. Alzheimer's. Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-11-88","article-title":"Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease","volume":"11","author":"Isaias","year":"2011","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib119","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1523\/JNEUROSCI.6588-10.2011","article-title":"Opposing roles of nucleus accumbens core and shell dopamine in the modulation of limbic information processing","volume":"31","author":"Ito","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2022.09.007_bib120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4439(00)00036-3","article-title":"Properties of NACP\/\u03b1-synuclein and its role in Alzheimer\u2019s disease","volume":"Vol. 1502","author":"Iwai","year":"2000","journal-title":"Biochim. Et. Biophys. Acta BBA Mol. Basis Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib121","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A\u03b2 component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2022.09.007_bib122","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/bi00032a006","article-title":"Non-A beta component of Alzheimer\u2019s disease amyloid (NAC) is amyloidogenic","volume":"34","author":"Iwai","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib123","article-title":"Dysbiosis and Alzheimer\u2019s disease: cause or treatment opportunity?","author":"Janeiro","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/nano10050832","article-title":"\u03b1-synuclein oligomer detection with aptamer switch on reduced graphene oxide electrode","volume":"10","author":"Jang","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ibneur.2022.09.007_bib125","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/brain\/awx361","article-title":"Parkinson's disease tremors and serotonin","volume":"141","author":"Jankovic","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2022.09.007_bib126","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/archneur.58.10.1611","article-title":"Functional decline in Parkinson disease","volume":"58","author":"Jankovic","year":"2001","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.ibneur.2022.09.007_bib127","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson\u2019s disease. Changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer\u2019s disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"key":"10.1016\/j.ibneur.2022.09.007_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107806","article-title":"Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease","volume":"170","author":"Jim\u00e9nez-S\u00e1nchez","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuron.2015.11.028","article-title":"Relationships between pupil diameter and neuronal activity in the locus coeruleus, colliculi, and cingulate cortex","volume":"89","author":"Joshi","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2022.09.007_bib131","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.parkreldis.2008.05.007","article-title":"Dementia and visual hallucinations associated with limbic pathology in Parkinson\u2019s disease","volume":"15","author":"Kalaitzakis","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib132","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib133","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/18756190MTA3fMTUq5","article-title":"Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated Parkinson\u2019s disease","volume":"19","author":"Kaur","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib134","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/nm.4001","article-title":"Proteostasis and aging","volume":"21","author":"Kaushik","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ibneur.2022.09.007_bib135","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2003.11.005","article-title":"\u03b1-Synuclein, Parkinson\u2019s disease, and Alzheimer's disease","volume":"10","author":"Kim","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib136","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2022.09.007_bib137","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cne.11005","article-title":"GABAergic projection from the ventral tegmental area and substantia nigra to the periaqueductal gray region and the dorsal raphe nucleus","volume":"469","author":"Kirouac","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib138","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpneuro0126","article-title":"The genetics of Parkinson disease: implications for neurological care","volume":"2","author":"Klein","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib139","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota axis in Alzheimer\u2019s disease","volume":"25","author":"Kowalski","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"10.1016\/j.ibneur.2022.09.007_bib140","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.ccr.2009.05.011","article-title":"Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation","volume":"253","author":"Kozlowski","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib141","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neurobiolaging.2019.09.001","article-title":"Pupillary dilation responses as a midlife indicator of risk for Alzheimer\u2019s disease: association with Alzheimer's disease polygenic risk","volume":"83","author":"Kremen","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2022.09.007_bib142","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/WAD.0b013e3181a6f101","article-title":"Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer\u2019s disease","volume":"24","author":"Krueger","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib143","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fnins.2020.00305","article-title":"Nanotheranostic applications for detection and targeting neurodegenerative diseases","volume":"14","author":"Kumar","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051115","article-title":"Alpha-synuclein and LRRK2 in synaptic autophagy: linking early dysfunction to late-stage pathology in Parkinson\u2019s disease","volume":"9","author":"Lamonaca","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ibneur.2022.09.007_bib145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncir.2018.00021","article-title":"Neuromodulatory correlates of pupil dilation","volume":"12","author":"Larsen","year":"2018","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.ibneur.2022.09.007_bib146","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib147","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwj283","article-title":"Serum cholesterol levels and the risk of Parkinson\u2019s disease","volume":"164","author":"de Lau","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib148","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10072-014-1645-4","article-title":"COMT Val158Met and PPAR\u03b3 Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis","volume":"35","author":"Lee","year":"2014","journal-title":"Neurol. Sci.: Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib149","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12035-012-8267-8","article-title":"Inflammation and \u03b1-synuclein\u2019s prion-like behavior in Parkinson's disease--is there a link?","volume":"47","author":"Lema Tom\u00e9","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archneur.63.3.370","article-title":"Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype","volume":"63","author":"Leverenz","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib151","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1096\/fj.03-0770fje","article-title":"Dopamine and L\u2010dopa disaggregate amyloid fibrils: implications for Parkinson\u2019s and Alzheimer's disease","volume":"18","author":"Li","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ibneur.2022.09.007_bib152","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer\u2019s disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib153","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson's disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib154","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neubiorev.2017.10.023","article-title":"Magnetic resonance imaging of the human locus coeruleus: a systematic review","volume":"83","author":"Liu","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2005.04.019","article-title":"Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered l-DOPA","volume":"1046","author":"Maeda","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib156","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2022.09.007_bib157","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopsych.2008.01.018","article-title":"Decreased volume of the brain reward system in alcoholism","volume":"64","author":"Makris","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib158","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresrev.2004.02.002","article-title":"Noradrenergic mechanisms in neurodegenerative diseases: a theory","volume":"45","author":"Marien","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib159","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-200306","article-title":"Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease","volume":"78","author":"Marizzoni","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/alzrt109","article-title":"Examining the mechanisms that link \u03b2-amyloid and \u03b1-synuclein pathologies","volume":"4","author":"Marsh","year":"2012","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ibneur.2022.09.007_bib161","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnagi.2014.00252","article-title":"Is dopamine involved in Alzheimer\u2019s disease?","volume":"6","author":"Martorana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib162","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","article-title":"The locus coeruleus: essential for maintaining cognitive function and the aging brain","volume":"20","author":"Mather","year":"2016","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib163","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000051243","article-title":"Genetic association between Alzheimer disease and the alpha-synuclein gene","volume":"12","author":"Matsubara","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib164","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3389\/fimmu.2017.01489","article-title":"The cholinergic system modulates memory and hippocampal plasticity its interactions with non-neuronal cells","volume":"8","author":"Maurer","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/mds.26421","article-title":"Neuropathology of \u03b1-synuclein propagation and braak hypothesis","volume":"31","author":"McCann","year":"2016","journal-title":"Mov. Disord."},{"issue":"Pt B","key":"10.1016\/j.ibneur.2022.09.007_bib166","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.brainres.2016.01.036","article-title":"Specificity and impact of adrenergic projections to the midbrain dopamine system","volume":"1641","author":"Mejias-Aponte","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib167","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.13050","article-title":"Early compensatory responses against neuronal injury: a new therapeutic window of opportunity for Alzheimer\u2019s Disease?","volume":"25","author":"Merlo","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ibneur.2022.09.007_bib168","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1002\/cne.23415","article-title":"Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer\u2019s disease","volume":"521","author":"Mesulam","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ibneur.2022.09.007_bib170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2006.06.003","article-title":"Allelic variation of a functional promoter polymorphism of the serotonin transporter and depression in Parkinson's disease","volume":"13","author":"M\u00f6ssner","year":"2007","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib171","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0306-4522(96)00452-6","article-title":"Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra","volume":"76","author":"Moukhles","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2022.09.007_bib172","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnana.2020.00026","article-title":"Interactions between the serotonergic and other neurotransmitter systems in the basal ganglia: role in parkinson\u2019s disease and adverse effects of L-DOPA","volume":"14","author":"Mu\u00f1oz","year":"2020","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ibneur.2022.09.007_bib173","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurobiolaging.2014.10.017","article-title":"Low concentrations of ethanol protect against synaptotoxicity induced by A\u03b2 in hippocampal neurons","volume":"36","author":"Mu\u00f1oz","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2022.09.007_bib174","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3940(95)12298-2","article-title":"No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms","volume":"204","author":"Nanko","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2022.09.007_bib176","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/revneuro-2013-0004","article-title":"Prefrontal dopamine signaling and cognitive symptoms of Parkinson\u2019s disease","volume":"24","author":"Narayanan","year":"2013","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib177","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/npp.2011.82","article-title":"Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity","volume":"36","author":"Nikolova","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ibneur.2022.09.007_bib179","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/03009730903573246","article-title":"Serotonin, genetic variability, behaviour, and psychiatric disorders--a review","volume":"115","author":"Nordquist","year":"2010","journal-title":"Upsala J. Med. Sci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson\u2019s disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ibneur.2022.09.007_bib181","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.mp.4000417","article-title":"The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease","volume":"3","author":"Oliveira","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ibneur.2022.09.007_bib182","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2017.04.006","article-title":"Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson\u2019s disease model","volume":"293","author":"Oliveira","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2012.12.004","article-title":"Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines","volume":"44","author":"Orme\u00f1o","year":"2013","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib184","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00702-017-1823-7","article-title":"The serotonergic system in Parkinson\u2019s patients with dyskinesia: evidence from imaging studies","volume":"125","author":"Pagano","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ibneur.2022.09.007_bib185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mehy.2013.11.016","article-title":"Uptake of environmental toxicants by the locus ceruleus: a potential trigger for neurodegenerative, demyelinating and psychiatric disorders","volume":"82","author":"Pamphlett","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ibneur.2022.09.007_bib186","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ibneur.2022.09.007_bib187","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.taap.2011.05.006","article-title":"Association between environmental exposure to pesticides and neurodegenerative diseases","volume":"256","author":"Parr\u00f3n","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib188","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/awx376","article-title":"Progression of tremor in early stages of Parkinson's disease: a clinical and neuroimaging study","volume":"141","author":"Pasquini","year":"2018","journal-title":"Brain: a J. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib189","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.parkreldis.2019.03.025","article-title":"Progressive loss of raphe nuclei serotonin transporter in early Parkinson\u2019s disease: a longitudinal I-FP-CIT SPECT study","volume":"77","author":"Pasquini","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib190","first-page":"1","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib191","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2318-8-36","article-title":"Smoking, dementia and cognitive decline in the elderly, a systematic review","volume":"8","author":"Peters","year":"2008","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.ibneur.2022.09.007_bib192","first-page":"404","article-title":"Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer\u2019s type","volume":"10","author":"Pinto","year":"2011","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib193","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","article-title":"Serotonin in Parkinson\u2019s disease","volume":"277","author":"Politis","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib194","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the -synuclein gene identified in families with parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2022.09.007_bib195","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2022.09.007_bib196","first-page":"e202","article-title":"A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson\u2019s disease","volume":"24","author":"Pouclet","year":"2012","journal-title":"Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc."},{"key":"10.1016\/j.ibneur.2022.09.007_bib197","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3233\/JAD-2009-0950","article-title":"Psychotic symptoms in Alzheimer\u2019s disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association","volume":"16","author":"Quaranta","year":"2009","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"key":"10.1016\/j.ibneur.2022.09.007_bib198","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.baga.2017.08.001","article-title":"Genetic analysis of SNCA gene polymorphisms in Parkinson\u2019s disease in an Iranian population","volume":"10","author":"Rahimi","year":"2017","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.ibneur.2022.09.007_bib199","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0047-6374(01)00283-4","article-title":"Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson\u2019s disease?","volume":"122","author":"Rajagopalan","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib200","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1212\/WNL.0000000000001774","article-title":"Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia","volume":"85","author":"Rajan","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib201","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11064-020-03187-9","article-title":"Is gut dysbiosis an epicenter of Parkinson\u2019s disease?","volume":"46","author":"Rajput","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neures.2021.01.001","article-title":"Unravelling the role of gut microbiota in Parkinson\u2019s disease progression: pathogenic and therapeutic implications","volume":"168","author":"Rani","year":"2021","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib203","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric \u03b1-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.ibneur.2022.09.007_bib204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib205","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02785.x","article-title":"Reduced MPTP toxicity in noradrenaline transporter knockout mice","volume":"91","author":"Rommelfanger","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib206","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1073\/pnas.0702753104","article-title":"Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice","volume":"104","author":"Rommelfanger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2022.09.007_bib207","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson\u2019s disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib208","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jnc.14151","article-title":"Enhanced motivation to alcohol in transgenic mice expressing human \u03b1-synuclein","volume":"143","author":"Rotermund","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib209","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2174\/1567205013666160606100509","article-title":"The brainstem tau cytoskeletal pathology of Alzheimer\u2019s disease: a brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance","volume":"13","author":"R\u00fcb","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004390050816","article-title":"A functional polymorphism in the monoamine oxidase A gene promoter","volume":"103","author":"Sabol","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ibneur.2022.09.007_bib211","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archneurol.2010.135","article-title":"When does Parkinson disease start?","volume":"67","author":"Savica","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib212","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/jamaneurol.2017.4243","article-title":"When do \u03b1-synucleinopathies start? An epidemiological timeline: a review","volume":"75","author":"Savica","year":"2018","journal-title":"JAMA Neurol."},{"issue":"Issue 1","key":"10.1016\/j.ibneur.2022.09.007_bib213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ane.13028","article-title":"Lewy body pathology in Alzheimer\u2019s disease: a clinicopathological prospective study","volume":"Vol. 139","author":"Savica","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ibneur.2022.09.007_bib214","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","article-title":"In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals","volume":"74","author":"Sayre","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson\u2019s disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib216","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0140-6736(05)73376-6","article-title":"Aspects of Alzheimer\u2019s disease","volume":"355","author":"Scheltens","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ibneur.2022.09.007_bib217","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib218","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neurobiolaging.2016.01.012","article-title":"Impact of lifestyle dimensions on brain pathology and cognition","volume":"40","author":"Schreiber","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2022.09.007_bib219","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bpa.12168","article-title":"The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies","volume":"25","author":"Seidel","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib220","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3233\/JAD-210171","article-title":"Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to Alzheimer\u2019s disease: implications for treatment","volume":"82","author":"Serra","year":"2021","journal-title":"J. Alzheimer's. Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib221","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/nu13020690","article-title":"Crosstalk between gut and brain in Alzheimer\u2019s disease: the role of gut microbiota modulation strategies","volume":"13","author":"Shabbir","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ibneur.2022.09.007_bib222","first-page":"236re4","article-title":"An antidepressant decreases CSF A\u03b2 production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ibneur.2022.09.007_bib223","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnagi.2021.636545","article-title":"The association between the gut microbiota and parkinson\u2019s disease, a meta-analysis","volume":"13","author":"Shen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib224","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1523\/JNEUROSCI.1666-18.2018","article-title":"New frontiers in Parkinson\u2019s disease: from genetics to the clinic","volume":"38","author":"Shihabuddin","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib225","first-page":"550","article-title":"[Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12]","volume":"45","author":"Shishov","year":"2009","journal-title":"Prikl. Biokhimiia Mikrobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib226","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006370","article-title":"Dorsal anterior cingulate-brainstem ensemble as a reinforcement meta-learner","volume":"14","author":"Silvetti","year":"2018","journal-title":"PLOS Comput. Biol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib227","series-title":"Multiscale Models of Brain Disorders","first-page":"127","article-title":"A computational hypothesis on how serotonin regulates catecholamines in the pathogenesis of depressive apathy","author":"Silvetti","year":"2019"},{"key":"10.1016\/j.ibneur.2022.09.007_bib228","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2990.2009.01038.x","article-title":"Does Alzheimer\u2019s disease begin in the brainstem?","volume":"35","author":"Simic","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib229","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u2019s disease","volume":"151","author":"\u0160imi\u0107","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/00207454.2019.1667799","article-title":"Noradrenergic pathways of locus coeruleus in Parkinson\u2019s and Alzheimer\u2019s pathology","volume":"130","author":"Singh","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib231","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0306-4522(98)00202-4","article-title":"Cholinergic neurons of the nucleus basalis of Meynert receive cholinergic, catecholaminergic and GABAergic synapses: an electron microscopic investigation in the monkey","volume":"88","author":"Smiley","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2022.09.007_bib232","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nbd.2017.05.007","article-title":"Molecular imaging of serotonin degeneration in mild cognitive impairment","volume":"105","author":"Smith","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib233","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s40478-019-0787-2","article-title":"Unique \u03b1-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression","volume":"7","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ibneur.2022.09.007_bib234","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2022.09.007_bib235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"Pt B","key":"10.1016\/j.ibneur.2022.09.007_bib236","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib237","first-page":"1","article-title":"Evaluating the relationship between amyloid-\u03b2 and \u03b1-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson\u2019s disease","volume":"6","author":"Swirski","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ibneur.2022.09.007_bib238","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(02)00258-6","article-title":"Association of monoamine oxidase A gene polymorphism with Alzheimer\u2019s disease and Lewy body variant","volume":"327","author":"Takehashi","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2022.09.007_bib239","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcimb.2020.00151","article-title":"Current sampling methods for gut microbiota: a call for more precise devices","volume":"10","author":"Tang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","article-title":"Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery","volume":"13","author":"Theofilas","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.ibneur.2022.09.007_bib241","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/archneur.63.12.1724","article-title":"Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline","volume":"63","author":"Tong","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib242","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.alcohol.2015.09.001","article-title":"Alcohol-induced alterations in dopamine modulation of prefrontal activity","volume":"49","author":"Trantham-Davidson","year":"2015","journal-title":"Alcohol"},{"key":"10.1016\/j.ibneur.2022.09.007_bib243","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease. translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ibneur.2022.09.007_bib244","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/01.wnl.0000271377.52421.4a","article-title":"Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment","volume":"69","author":"Truchot","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2022.09.007_bib245","first-page":"115","article-title":"Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography","volume":"372","author":"Tsavkelova","year":"2000","journal-title":"Dokl. Biochem. Proc. Acad. Sci. USSR Biochem. Sect."},{"key":"10.1016\/j.ibneur.2022.09.007_bib246","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ibneur.2022.09.007_bib247","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib248","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson\u2019s disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib249","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3233\/JAD-170364","article-title":"Alzheimer\u2019s disease: the alternative serotonergic hypothesis of cognitive decline","volume":"60","author":"Vakalopoulos","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ibneur.2022.09.007_bib250","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cne.903340408","article-title":"Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents","volume":"334","author":"Van Bockstaele","year":"1993","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib251","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(93)90077-Z","article-title":"Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens","volume":"624","author":"Van Bockstaele","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib252","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1750-3639.2011.00540.x","article-title":"The proteome of the locus ceruleus in Parkinson\u2019s disease: relevance to pathogenesis","volume":"22","author":"van Dijk","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib253","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.envint.2012.05.004","article-title":"Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies","volume":"46","author":"Van Maele-Fabry","year":"2012","journal-title":"Environ. Int."},{"key":"10.1016\/j.ibneur.2022.09.007_bib254","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","article-title":"Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: The locus coeruleus story","volume":"102","author":"Vermeiren","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ibneur.2022.09.007_bib255","doi-asserted-by":"crossref","first-page":"E6506","DOI":"10.1073\/pnas.1606791113","article-title":"Environmental and genetic factors support the dissociation between \u03b1-synuclein aggregation and toxicity","volume":"113","author":"Villar-Piqu\u00e9","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ibneur.2022.09.007_bib256","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/mds.25789","article-title":"Alimentary, my dear Watson? The challenges of enteric \u03b1-synuclein as a Parkinson\u2019s disease biomarker","volume":"29","author":"Visanji","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib257","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/membranes11060385","article-title":"Molecular and ionic diffusion in ion exchange membranes and biological systems (Cells and Proteins) studied by NMR","volume":"11","author":"Volkov","year":"2021","journal-title":"Membranes"},{"key":"10.1016\/j.ibneur.2022.09.007_bib258","doi-asserted-by":"crossref","first-page":"26285","DOI":"10.1038\/srep26285","article-title":"\u03b1-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2022.09.007_bib259","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/jcla.21986","article-title":"SNCAGene polymorphism may contribute to an increased risk of Alzheimer\u2019s disease","volume":"30","author":"Wang","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ibneur.2022.09.007_bib260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/01616412.2018.1564183","article-title":"COMT Val158Met polymorphism and Parkinson\u2019s disease risk: a pooled analysis in different populations","volume":"41","author":"Wang","year":"2019","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ibneur.2022.09.007_bib261","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/cbic.201300262","article-title":"Biophysical studies of the amyloid \u03b2-peptide: interactions with metal ions and small molecules","volume":"14","author":"W\u00e4rml\u00e4nder","year":"2013","journal-title":"Chembiochem A Eur. J. Chem. Biol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib262","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-981-32-9358-8_19","article-title":"Tau accumulation and network breakdown in Alzheimer's disease","volume":"1184","author":"Watanabe","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib263","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tins.2018.01.010","article-title":"Long road to ruin: noradrenergic dysfunction in neurodegenerative disease","volume":"41","author":"Weinshenker","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib264","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1460-9568.2006.04900.x","article-title":"Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein","volume":"24","author":"Wersinger","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00741-z","article-title":"Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer\u2019s disease","volume":"13","author":"Whiley","year":"2021","journal-title":"Alzheimer's. Res. Ther."},{"key":"10.1016\/j.ibneur.2022.09.007_bib266","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1474-4422(17)30056-X","article-title":"Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies","volume":"16","author":"Wile","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib267","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00415-009-0899-x","article-title":"No evidence for association between an MAOA functional polymorphism and susceptibility to Parkinson's disease","volume":"256","author":"Williams-Gray","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib268","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2022.09.007_bib269","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/aje\/kwq303","article-title":"Metal emissions and urban incident Parkinson disease: a community health study of medicare beneficiaries by using geographic information systems","volume":"172","author":"Willis","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib270","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(19)30140-1","article-title":"Serotonergic pathology and disease burden in the premotor and motor phase of A53T \u03b1-synuclein parkinsonism: a cross-sectional study","volume":"18","author":"Wilson","year":"2019","journal-title":"Lancet Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.ibneur.2022.09.007_bib271","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib272","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.cortex.2012.03.017","article-title":"Linking neurogenetics and individual differences in language learning: the dopamine hypothesis","volume":"48","author":"Wong","year":"2012","journal-title":"Cortex J. Devoted Study Nerv. Syst. Behav."},{"key":"10.1016\/j.ibneur.2022.09.007_bib273","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0064-7","article-title":"The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer\u2019s disease and vascular dementia: focusing on fluoxetine with long follow-up periods","volume":"4","author":"Xie","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ibneur.2022.09.007_bib274","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000447324","article-title":"Association study and meta-analysis of polymorphisms, methylation profiles, and peripheral mRNA expression of the serotonin transporter gene in patients with Alzheimer\u2019s disease","volume":"41","author":"Yamazaki","year":"2016","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.ibneur.2022.09.007_bib275","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jns.2016.01.014","article-title":"Association between polymorphism of COMT gene (Val158Met) with Alzheimer's disease: an updated analysis","volume":"361","author":"Yan","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ibneur.2022.09.007_bib276","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2006.04098.x","article-title":"Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice","volume":"99","author":"Yavich","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2022.09.007_bib277","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib278","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/cercor\/bhv172","article-title":"Resting-state functional connectivity of the locus coeruleus in humans: in comparison with the ventral tegmental area\/substantia nigra pars compacta and the effects of age","volume":"26","author":"Zhang","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ibneur.2022.09.007_bib279","first-page":"533","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ibneur.2022.09.007_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2014.03.002","article-title":"Serotonin transporter polymorphic region 5-HTTLPR modulates risk for Parkinson\u2019s disease","volume":"35","author":"Zhang","year":"2014","journal-title":"Neurobiol. Aging"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242122000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242122000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:13:08Z","timestamp":1757405588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242122000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":280,"alternative-id":["S2667242122000690"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2022.09.007","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2022.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}